U.S. Markets close in 3 hrs 8 mins

Amazon.com, Inc. (AMZN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
971.906-18.42 (-1.86%)
As of 12:52PM EDT. Market open.
People also watch
GOOGAAPLFBNFLXTSLA
  • Believing this is a long term hold, my strategy is to buy on the dips to add to my position. This an ideal stock for this. Of course you do need to have money to invest and the stomach for it. Never sell.
  • LOL Tweets they don't pay taxes, coming from a guy that does not pay taxes. Ironic don't you think...
    Imagedarkskyparadise96
  • this stock is worth 75 usd not 1000 this is #$%$ stop buying for the sack of sellimg it higher. you guys are like people buying houses in the 2007 boom!
  • There's my $988 "inflection" folks.
    Stays below? Going to $899.
    Stays above? Going to $1065.

    ONLY trade the info/technicals folks!
    Enjoy.
  • All you bashers out there I wonder if you really have the nuts to short it !
  • 186 p/e hint hint
  • Shorts be like...
    Imageeverythingstarstuff
  • Can't wait to lose some money today.
  • Last chance to get in under $1,000.
  • And the downtrend continues - NASDAQ setting up for a bad opening.
  • Short squeeze in process. Then start again, LOL. Beautiful, if you can time it right a lot of money can be made.
  • BACK-TAXES, All the way back to 1998 being paid, could be very large.
  • Why is it down? They told me this was a good one.
  • Doanald Thrump is rite. wance AOMAZON stats paing salz taz dey er doomd , sell sell sell
  • Horrible price action in AMZN - trend is definitely lower. Could in the 950 range before end of day.
  • Stephen Alan "Steve" Wynn, (born January 27, 1942). Wynn has publicly self-identified as a supporter of the Democratic Party in the United States.
  • Walls street controllers trying their best to continue to prop this overvalued stock up... who’s gonna win? Bulls or Bears. My money is on the bears finally taking this bloated internet retailer down for awhile
  • Would you believe that Amazon made only 4B profit since 1997 and that Walmart made 16B profit just in 2016 alone? I hate Walmart but I am just saying AMZN is becoming a big bubble.
  • LOAD UP SOME IGXT MAJOR BREAKOUT IMMINENT ...
    IGXT (MC $50 M) NDA filing for BLOCKBUSTER thin-flim Cialis (BETTER THAN Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .A LIFETIME OPPORTUNITY HERE GUYS !!!

    2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $50 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .GL

    Intelgenx (IGXT)

    MarketCap $50 Million
    Cash ~$12 Million (including convertible debt) =cash untill 2021+
    Price: 0.80

    NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July
    NDA resubmission for Rizaport (migraine) in early Q3
    Partnership for Tadalafil in 2H 2017

    http://www.biotuesdays.com/features/2017/5/11/intelgenx-has-multi-faceted-bd-approach-for-its-oral-films

    IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.

    Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.

    IntelGenx has multi-faceted BD approach for its oral films
    With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
    www.biotuesdays.com
  • its not going to go up forever!